These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2405169)
41. Clinical pharmacologic study of 1-acetyl-2-picolinoyl hydrazine (NSC-68626). Laszlo J; Durant J; Loeb V Cancer Chemother Rep; 1969 Apr; 53(2):131-4. PubMed ID: 4895097 [No Abstract] [Full Text] [Related]
42. Malignant hepatoma--controlled therapeutic trials. South African primary liver cancer research group. Initial report. S Afr Med J; 1967 Mar; 41(12):309-14. PubMed ID: 4290232 [No Abstract] [Full Text] [Related]
43. Use of hydrazine sulfate in terminal and preterminal cancer patients: results of investigational new drug (IND) study in 84 evaluable patients. Gold J Oncology; 1975; 32(1):1-10. PubMed ID: 1208024 [TBL] [Abstract][Full Text] [Related]
44. Supportive care drug studies: some promising, some not. Oncology (Williston Park); 1992 Sep; 6(9):93-4. PubMed ID: 1333264 [No Abstract] [Full Text] [Related]
46. [Treatment of Hodgkin's disease with Natulan]. Anglesio E Minerva Med; 1965 Dec; 56(100):4402-6. PubMed ID: 5324896 [No Abstract] [Full Text] [Related]
47. [First clinical experiences with methylhydrazine in treatment of malignant lymphogranuloma]. Fazio M; Cavallero P; Sartoris S; Vergnano F; Pegoraro L Minerva Med; 1965 Dec; 56(99):4338-43. PubMed ID: 5323491 [No Abstract] [Full Text] [Related]
48. [Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects]. Kummer H; Bucher U Schweiz Med Wochenschr; 1965 Sep; 95(37):1233-40. PubMed ID: 5863643 [No Abstract] [Full Text] [Related]
49. Treatment of carcinoma of the lung with 1-acetyl-2-picolinoylhydrazine (NSC-68626). Wilson KS; Ricci JA; Grobmyer AJ Cancer Chemother Rep; 1970 Aug; 54(4):243-4. PubMed ID: 4946008 [No Abstract] [Full Text] [Related]
50. A review of the antineoplastic action of certain hydrazines and hydrazine-containing natural products. Toth B In Vivo; 1996; 10(1):65-96. PubMed ID: 8726813 [TBL] [Abstract][Full Text] [Related]
51. Management of anorexia-cachexia associated with cancer and HIV infection. Gorter R Oncology (Williston Park); 1991 Sep; 5(9 Suppl):13-7. PubMed ID: 1721521 [TBL] [Abstract][Full Text] [Related]
52. [Trial of treatment of Hodgkin's disease and other lymphomas with a methylhydrazine, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride]. Berumen L; Franco Guevara G Rev Med Hosp Gen (Mex); 1965 Mar; 28(3):175-82. PubMed ID: 5318927 [No Abstract] [Full Text] [Related]
53. [Recent cytostatic therapy in hemoblastosis and malignant tumors]. Kühböck J; Mannheimer E Wien Klin Wochenschr; 1966 Jul; 78(26):487-8. PubMed ID: 5992456 [No Abstract] [Full Text] [Related]
55. [The action of Natulan in 94 cases of solid tumors]. Kenis Y; De Smedt J; Tagnon HJ Eur J Cancer (1965); 1966 Feb; 2(1):51-7. PubMed ID: 5962294 [No Abstract] [Full Text] [Related]
56. Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy. Mones RJ N Y State J Med; 1974 Jan; 74(1):47-51. PubMed ID: 4591989 [No Abstract] [Full Text] [Related]
57. Cancerostatics. Part V. Synthesis of some acyl hydrazine derivatives. Balicki R; Nantka-Namirski P Acta Pol Pharm; 1988; 45(1):1-7. PubMed ID: 3138893 [No Abstract] [Full Text] [Related]
58. [Results of the use of hydrazine sulfate in lymphogranulomatosis]. Danova LA; Kondrat'ev VB; Gershanovich ML; Filov VA Ter Arkh; 1977; 49(8):45-7. PubMed ID: 929394 [No Abstract] [Full Text] [Related]
59. Pharmacologic aspects of the chemotherapy of solid tumors. DeVita VT; Rall DP Pharmacol Physicians; 1968 Sep; 2(9):1-6. PubMed ID: 5743792 [No Abstract] [Full Text] [Related]
60. [Selective action of hydrazine sulfate in combination with thiophosphamide on tumor cell mitochondria]. Tret'iakov AV; Golovatova VA; Filov VA Vopr Onkol; 1982; 28(3):86-8. PubMed ID: 6461132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]